- Grants since 2016
- 145
- Awarded, last 5 years (where amounts are published)
- $500k
- Funded works, last 5 years
- 1 228
- Funded works, all time
- 2 889
Grants
2026–2027 · research · SU2C-TORREY COAST FOUNDATION RADIOPHARMACEUTICALS FOR GASTROINTESTINAL CANCERS NEW DISCOVERY CHALLENGE
Developing Next-generation Radionuclide Theranostics for Upper Gastrointestinal Tumors
Ken Herrmann · Dana-Farber Cancer Institute
2025–2027 · research · SU2C-TORREY COAST FOUNDATION RADIOPHARMACEUTICALS FOR GASTROINTESTINAL CANCERS NEW DISCOVERY CHALLENGE
Development of Claudin 18.2 Radiotheranostics for Battling Upper GI Cancers
Shadi Abdar Esfahani · Massachusetts General Hospital
2025–2029 · research · SU2C CATALYST® RESEARCH TEAM GRANT PROGRAM WITH SUPPORT FROM JOHNSON & JOHNSON PHARMACEUTICALS
A Phase 2 Clinical Trial of Teclistamab and Daratumumab in Previously Untreated AL Amyloidosis
Suzanne Lentzsch · Boston Medical Center
2025–2026 · research · SU2C-TORREY COAST FOUNDATION RADIOPHARMACEUTICALS FOR GASTROINTESTINAL CANCERS NEW DISCOVERY CHALLENGE
Theranostics for the Treatment of Gastroesophageal Cancer
Jason Lewis · Memorial Sloan Kettering Cancer Center
2025 · research · SU2C Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award
SU2C Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award 2025: Sarah Shelton
Sarah Shelton
2025–2028 · research · SU2C GASTRIC CANCER INTERCEPTION DREAM TEAM
Early Detection and Interception of Diffuse and Intestinal Gastric Cancer
Andrew T. Chan · University of Oxford
2024 · research · Cless Family Foundation Gastric Cancer Innovation in Collaboration Award
Cless Family Foundation Gastric Cancer Innovation in Collaboration Award 2024: Christina Curtis
Christina Curtis
2024 · research · Phillip A. Sharp Innovation in Collaboration Award (Class of 2024)
NEOADJUVANT IMMUNE CHECKPOINT BLOCKADE IN MISMATCH REPAIR PROFICIENT LOCALLY ADVANCED RECTAL CANCER
Andrea Cercek
2024 · research · SU2C Maverick Award
SU2C Maverick Award 2024: Marty Taylor
Marty Taylor
2024–2027 · research · SU2C CATALYST® RESEARCH GRANT PROGRAM WITH SUPPORT FROM ZENTALIS PHARMACEUTICALS
Therapeutically Targeting WEE1 in HPV+ Head and Neck Cancer
Bruce Clurman · Fred Hutch Cancer Center
2024–2026 · research · SU2C CONVERGENCE™– TORREY COAST FOUNDATION RESEARCH TEAM
Defining the Neoantigen and TCR Landscape to Inform Vaccine Approaches in Gastroesophageal Cancer
Gad A. Getz · Massachusetts General Hospital
2024 · research · Phillip A. Sharp Innovation in Collaboration Award (Class of 2024)
BACTERIAL WHISPERS: SMALL-TALK SHAPES MAMMALIAN IMMUNITY
Shawn Davidson
2024 · research · SU2C Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award
SU2C Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award 2024: William Freed-Pastor
William Freed-Pastor
2024 · research · The Ziskin Prize
The Ziskin Prize 2024: Marilyne Labrie
Marilyne Labrie
2024–2026 · research · SU2C CONVERGENCE™ – TORREY COAST FOUNDATION RESEARCH TEAM
Optimal vaccine design for Gastric Esophageal Cancer
Benjamin Greenbaum · Weill Cornell Medicine
2023 · research · Phillip A. Sharp Innovation in Collaboration Award (Class of 2023)
THERAPEUTIC BIPARATOPIC ANTIBODIES TARGETING FGFR2 IN GASTRIC CANCER
William Sellers
2023–2025 · research · THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER
Accelerating and Diversifying Access to Clinical Trials (adacT)
Martin Edelman · Fox Chase Cancer Center
2023 · research · Phillip A. Sharp - Laura Ziskin Innovation in Collaboration Award
DEVELOPMENT OF MICROFLUIDIC BLOOD EXCHANGE AS A NEXT-GENERATION PARABIOSIS FOR TUMOR/MICROBIOTA IMMUNOLOGY
Raby Upadhyay
2023–2025 · research · UNIVERSITY OF SOUTHERN CALIFORNIA
Eliminating Enrollment Barriers to Early Phase Trials in a Diverse Population in Los Angeles County
Anthony El-Khoueiry · University of Southern California
2023–2026 · research · VAN ANDEL INSTITUTE – SU2C CANCER EPIGENETICS DREAM TEAM
VAN ANDEL INSTITUTE – SU2C CANCER EPIGENETICS DREAM TEAM
Peter Jones · St. Jude Children's Research Hospital
2023–2025 · research · UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
Transferring Care to Enhance Access to Early-phase Cancer Clinical Trials
David Gerber · The University of Texas Southwestern Medical Center
2023–2026 · research · SU2C-TORREY COAST FOUNDATION GASTROESOPHAGEAL CANCER RESEARCH TEAM
Targeting Immune Evasion in Gastroesophageal Cancer
Yelena Janjigian · Memorial Sloan Kettering Cancer Center
2023 · research · Phillip A. Sharp Innovation in Collaboration Award (Class of 2023)
DEFINING IMMUNOTHERAPY POTENTIAL IN GENOME INSTABILITY-DRIVEN SQUAMOUS CELL CARCINOMAS
Agata Smogorzewska
2023–2025 · research · UNIVERSITY OF CHICAGO
Enhancing Diversity in Early Phase Clinical Trials in an Urban Underserved Community
Walter Stadler · University of Chicago
2023–2026 · research · SU2C-TORREY COAST FOUNDATION GASTROESOPHAGEAL CANCER RESEARCH TEAM
Novel Therapeutic Approaches for Esophageal Squamous Cell Carcinoma (ESCC)
Anil K. Rustgi · Case Western Reserve University
2023–2027 · research · SU2C-TORREY COAST FOUNDATION GASTROESOPHAGEAL CANCER RESEARCH TEAM
Therapeutics for Gastroesophageal Adenocarcinoma: Application, Translation and Discovery
William Sellers · Broad Institute
2023 · research · SU2C Maverick Award
SU2C Maverick Award 2023: Alexander T. Pearson
Alexander T. Pearson
2022 · research · SU2C Maverick Award
SU2C Maverick Award 2022: Anirban Das
Anirban Das
2022–2027 · research · SU2C CATALYST® RESEARCH TEAM GRANT PROGRAM WITH SUPPORT FROM MIRATI THERAPEUTICS
Targeting Adaptive and Acquired Resistance to Direct KRAS Inhibition
Ryan B. Corcoran · The University of Texas MD Anderson Cancer Center
2022–2025 · research · SU2C CATALYST® RESEARCH TEAM WITH SUPPORT FROM JAZZ PHARMACEUTICALS
Identification of Combination Therapeutics Using JZP-815 for the Treatment of NSCLC
Fred R. Hirsch · New York University
2022–2025 · research · LUNG CANCER HEALTH EQUITY SU2C CATALYST® RESEARCH TEAM
Technology-Enabled Immunotherapy Monitoring in NYC Minority NSCLC Patients
Vamsidhar Velcheti · Icahn School of Medicine at Mount Sinai
2022–2027 · research · SU2C LUNG CANCER HEALTH DISPARITIES RESEARCH TEAM
Southeastern Consortium for Lung Cancer Health Disparities
Robert A. Winn · Virginia Commonwealth University
2022–2026 · research · SU2C CATALYST® RESEARCH TEAM WITH SUPPORT FROM JAZZ PHARMACEUTICALS
The LiFFT Study (Lurbinectedin in FET-Fusion Tumors)
Patrick Grohar · University of Iowa
2022 · research · The Ziskin Prize
The Ziskin Prize 2022: Jane E. Visvader
Jane E. Visvader
2021–2026 · research · SU2C HEALTH EQUITY BREAKTHROUGH TEAM
DISRUPT: Diversity and IncluSion in Research UnderPinning Trials
Nina A. Bickell · Icahn School of Medicine at Mount Sinai
2021–2027 · research · SU2C-CRUK PEDIATRIC CANCER NEW DISCOVERIES CHALLENGE DREAM TEAM
BRAINatomy 2: Optimizing Cognition After Brain Radiotherapy
Martin G. Mccabe · University Medical Center Groningen
2021–2025 · research · SU2C COLORECTAL CANCER HEALTH EQUITY DREAM TEAM
Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening
Jennifer Haas · University of California, Los Angeles
2021–2028 · research · SU2C-CRUK PEDIATRIC CANCER NEW DISCOVERIES CHALLENGE RESEARCH TEAM
Combinatorial Targeting of Oncogene-Driven Childhood Cancer
John Anderson · University College London
2021 · research · Pancreatic Cancer Collective Phillip A. Sharp Challenge Award
Pancreatic Cancer Collective Phillip A. Sharp Challenge Award 2021: Alec Kimmelman
Alec Kimmelman
2021–2024 · research · STAND UP TO CANCER – FANCONI ANEMIA RESEARCH FUND – FARRAH FAWCETT FOUNDATION HEAD AND NECK CANCER RESEARCH TEAM
Precision Therapy for Fanconi Anemia and HPV-Related Head and Neck Cancers
Agata Smogorzewska · Yale University